Regenexx-C Hip Treatment Failure

Published on Sep 18, 2012

As I have blogged before, hips are harder to treat with stem cells than knees. Since we’ve had a run of “rah rah” posts on positive outcomes, it’s time for a post to balance the picture with a Regenexx-C hip treatment failure outcome. VK was a 53 year old man with hip problems since childhood. By adulthood these problems quieted down and he was better until 2006 when he injured his hip during martial arts. At that point an x-ray showed moderate to severe hip arthritis. He was first seen in 8/09 with a recent MRI also showing a hip bursitis and a gluteal muscle tear. His pain was between low level 1-2/10 and moderate level 5-6/10. He was placed in the POOR-FAIR candidacy grade, but wanted to avoid a hip replacement and try the Regenexx-C procedure instead. In October of 2009 he underwent a single Regenex-C treatment into the hip. His result? He reported no improvement and eventually did get a hip replacement. The upshot? Hips generally don’t respond as well as knees or other joints and other authors have commented on why. While we’ve seen some great successes with hips, we’ve also seen our share of treatment failures like VK. Stem cells aren’t magic, but tools that can fail like any other tools.

NOTE: The Regenexx-C procedure licensed by RegenexxCayman is not approved by the U.S. FDA for use in the United States. RegenexxCayman is an independently owned and operated medical services provider operating exclusively in the Cayman Islands and is not part of or affiliated with the Centeno-Schultz Clinic or any U.S. Regenexx Network provider.

Learn More About Regenexx^® Procedures

Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.

We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.